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ABSTRACT
Bone morphogenetic protein (BMP) signaling is required for early
forebrain development and cortical formation. How the endogenous
modulators of BMP signaling regulate the structural and functional
maturation of the developing brain remains unclear. Here, we show
that expression of the BMP antagonistGrem1marks committed layer
V and VI glutamatergic neurons in the embryonic mouse brain.
Lineage tracing ofGrem1-expressing cells in the embryonic brain was
examined by administration of tamoxifen to pregnant Grem1creERT;
Rosa26LSLTdtomato mice at 13.5 days post coitum (dpc), followed
by collection of embryos later in gestation. In addition, at 14.5 dpc,
bulkmRNA-seq analysis of differentially expressed transcripts between
FACS-sorted Grem1-positive and -negative cells was performed. We
also generated Emx1-cre-mediated Grem1 conditional knockout mice
(Emx1-Cre;Grem1flox/flox) in which the Grem1 gene was deleted
specifically in the dorsal telencephalon. Grem1Emx1cKO animals had
reduced cortical thickness, especially layers V and VI, and impaired
motor balance and fear sensitivity compared with littermate controls.
This study has revealed new roles for Grem1 in the structural and
functional maturation of the developing cortex.
KEY WORDS: Grem1, BMP, Cortical development, Excitatory
neuron, Mouse
INTRODUCTION
During development of the nervous system, bone morphogenetic
protein (BMP) signaling has important roles in the promotion of
dorsal identity, and the regulation of cell proliferation and
differentiation. Yet BMP function in the maturation of neurons in
vivo is poorly understood. Misregulation of BMP signaling has been
suggested to contribute to human neurodevelopmental conditions
such as autism spectrum disorders (Yamasaki et al., 2015; Chen
et al., 2017); however, a detailed understanding of the exact role for
BMP signaling in these disorders is lacking, in line with our
imperfect knowledge of the regulation of the BMP pathway in
normal brain development.
The BMP ligands (BMP2/4/5/6/7) bind to type I (BmprIA,
BmprIB, Acvr1) and type II (BmprII, ActrIIA, and ActrIIB)
receptors. BMP ligands are expressed broadly in the telencephalon
during early gestation inmice and then becomemore tightly localized
to the choroid plexus at 13.5 days post coitum (dpc) (Furuta et al.,
1997). BMPs have also been derived from the mesenchyme of the
brain, such as meninges and endothelial cells (Imura et al., 2008;
Choe and Pleasure, 2018). Both type I and II BMP receptors are
expressed in the telencephalon during development, but this is
restricted in adulthood to BmprII in the cortex and hippocampus and
ActrIIA/IIB in the dentate gyrus (Söderström et al., 1996). Aside
from this spatiotemporal regulation of receptors, the BMP signaling
pathway is also regulated by a family of secreted extracellular
antagonists that directly bind to the BMP ligands to prevent
interactions with BMP receptors both in development and disease
(Ali and Brazil, 2014). Antagonists such as gremlin 1 (Grem1),
noggin (Nog) and chordin (Chrd) have been shown to inhibit BMP
action in a range of different cell types and developmental stage-
specific contexts to provide exquisite spatiotemporal regulation of the
pathway. The roles of Nog and Chrd have been partially elucidated:
they are required for forebrain development (Bachiller et al., 2000), as
well as to create a niche for adult hippocampal neurogenesis (Lim
et al., 2000; Sun et al., 2007). The expression and function of Grem1
in the developing brain has not yet been determined. Grem1 is an
extracellular secreted antagonist of BMP2/4/7 that signals to intestinal
stem cells in the gut (Worthley et al., 2015) and plays a crucial role in
Xenopus dorsalization (Hsu et al., 1998) and limb and kidney
formation (Khokha et al., 2003). Likewise the role of Grem1 in the
normal adult CNS is unmapped territory to date, outside of previous
work in the pathogenic state of glioma (Yan et al., 2014; Guan et al.,
2017; Fu et al., 2018).
BMP signaling has been implicated in the regulation of forebrain
patterning during early embryogenesis, working together with
other signaling pathways such as fibroblast growth factor (FGF),
Wnt and Notch. High levels of BMP activity suppress anterior neural
development, whereas abrogation of BMP signaling can promote
neural specification (Wilson and Houart, 2004; Lamb et al., 1993;
Bachiller et al., 2000). In vitro the addition of BMP2 and 4 to mouse
neural stem cell cultures represses cell proliferation (Mathieu et al.,
2008). BMP ligands regulate neuronal differentiation as well as
determination of glial cell fate, by promoting astrocyte differentiation
at the expense of oligodendrocytic fates (Mathieu et al., 2008; Yun
et al., 2004; Sun and Xu, 2010; Gomes et al., 2003).
Radial glial cells (RGCs) begin to divide asymmetrically to start
producing neurons at around 11.5 dpc in mice. RGC daughter cells
detach from the ventricle and form the first neuronal layer of the
preplate by 13.5 dpc (Haubensak et al., 2004). Subsequently born
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neurons migrate along RGCs and start to form the cortical plate,
separating the preplate into Cajal-Retzius cells in the marginal zone
and subplate neurons (Nichols and Olson, 2010; Marin-Padilla,
1978). The neocortex develops in an inside-out manner, with deep
layers emerging first and superficial layers last. These neurons
differentiate into glutamatergic pyramidal neurons, whereas
inhibitory interneurons are born in the subcortical ganglionic
eminences. Deep-layer pyramidal neurons (DLPNs, layer V and VI)
have both intratelenchephalic projections to superficial cortical
layers and extracortical projections to other brain regions (Saiki
et al., 2017). Multiple molecular mechanisms regulate this
corticogenesis (Kowalczyk et al., 2009; Franco et al., 2012; Chen
et al., 2005); however, the role of BMP signaling in cortical layer
formation and functional maturation of neurons has only been
reported in limited studies so far. In utero electroporation of BMP7
to murine 14.5 dpc cortical ventricular cells impaired neuronal
migration, suggesting that BMP signaling regulates neuronal
positioning and migration (Choe and Pleasure, 2018). BMPs also
regulate dendritogenesis and neurite growth in vitro (Lee-Hoeflich
et al., 2004; Matsuura et al., 2007). This is consistent with a recent
study that suggests perturbation of BMP signaling by delivery of a
dominant-negative version of BMP IB receptor affects migration,
polarity and dendritogenesis of mouse cortical neurons in vivo
(Saxena et al., 2018).
To further establish the role of BMP signaling in forebrain
development and neuronal function, we focus here on the
expression and function of the BMP antagonist Grem1 in the
developing mouse brain. We first assessed Grem1 expression using
transgenic Grem1 reporter mice in the dorsal telencephalon and
developing neocortex. Next, to investigate the role of Grem1 in the
developing brain, we used transcriptomic analyses of sorted mouse
Grem1-expressing cells and single cell RNA-sequence (scRNA-
seq) data, combined with mouse neural stem/progenitor cell (NSPC)
culture ex vivo. Lastly, to examine the functional contribution of
Grem1 to cortical development, we conditionally deleted Grem1 in
the dorsal telencephalon and undertook behavioral testing of mutant
animals and littermate controls.
RESULTS
Grem1-expressing cells are located in the dorsal
telencephalon and give rise to deep-layer neocortical
neurons
Grem1 RNA was first detected by in situ hybridization (ISH)
in the mouse dorsal telencephalon at 13.5 dpc and expression
was maintained through embryonic development until 20.5 dpc
(Fig. S1A). To further assess Grem1 expression in the embryonic
mouse brain, we used transgenicGrem1creERT; Rosa26LSLTdtomato
reporter mice, in which tamoxifen treatment results in expression of
TdTomato in cells in which the Grem1 enhancer and promoter
sequences are active, and the progeny of those cells (Worthley et al.,
2015). Pregnant Grem1creERT; Rosa26LSLTdtomato mice were
administered tamoxifen at 11.5 dpc, the time point at which RGCs
begin dividing in the developing cortex, and embryonic brains were
collected 24 h later. Consistent with our Grem1 ISH analysis, no
TdTomato+ cells were observed, confirming that Grem1 is not yet
expressed in the brain at this early time-point (Fig. S1B). Next, we
administered tamoxifen to pregnant dams at 13.5 dpc when Grem1
is first expressed, and collected embryonic brains at 14.5, 17.5 and
20.5 dpc (Fig. 1A,B). From this time point we observed cells
expressing TdTomato 24 h after tamoxifen administration located in
the lower cortical plate and subplate of the dorsal telencephalon,
with dendrites extending to the pia mater (Fig. 1B,C). ISH
confirmed that Grem1 RNA was detected in almost all
TdTomato+ cells at 14.5 dpc, confirming that the reporter line
recapitulates endogenous Grem1 expression (Fig. 1D,E). Six days
later at 20.5 dpc, almost all layer V TdTomato+ cells still expressed
Grem1 RNA, whereas a significantly lower percentage of
TdTomato+ layer VI neurons continued to express Grem1 RNA
(Fig. 1D,E). Further co-staining of TdTomato+ cells with cell type-
and layer-specific markers showed that, at 20.5 dpc, the TdTomato+
cells have become Ctip2+ (Bcl11b+) layer V pyramidal neurons with
dendrites extending to the pia mater and layer VI neurons (Fig. 1I;
Fig. S1C). TdTomato+ cells did not express the layer II-IV marker,
CDP (Cux1) (Fig. S1C). Grem1 mRNA levels dramatically
decreased after birth as determined by qRT-PCR analysis of total
RNA isolated from mouse brain cortex at birth, postnatal day (P) 10
and 4 weeks post-birth (Fig. S1D).
To investigate when cells that become Grem1+ are born during
mouse cortical development, we administered the thymidine
analogue bromodeoxyuridine (BrdU) concomitantly with
tamoxifen to pregnant Grem1creERT; Rosa26LSLTdtomato dams
at 13.5 dpc when it will be incorporated into dividing RGCs and
intermediate progenitor cells (IPs) (Fig. 1A). We found that 55% of
TdTomato+ layer V pyramidal neurons cells were labelled with
BrdU at 17.5 dpc (Fig. 1F,G), demonstrating that these cells are
derived from progenitors at embryonic day (E)13.5, with Grem1
then expressed in committed layer V/VI neurons migrating over the
following 3 days towards the cortical plate. Fewer TdTomato+ cells
(17%) in layer VI were BrdU+ (Fig. 1F,G), consistent with layer VI
neurons starting to be born before E13.5. At 14.5 dpc, TdTomato+
cells were also Ki67− (Mki67−), suggesting that they were non-
proliferative (Fig. S1E). We subsequently assessed whether
TdTomato+ cells express a marker of post-mitotic mature neurons,
NeuN (Rbfox3), by immunohistochemistry (IHC). At 14.5 dpc
most TdTomato+ cells were NeuN− and were located in the
subplate, and lower NeuN+ cortical plate (Fig. 1H). In contrast, later
in gestation at 20.5 dpc almost all TdTomato+ cells in Ctip2-
strongly-positive layer V neurons and approximately half of Ctip2-
weakly-positive layer VI neurons expressed NeuN (Fig. 1I,J).
Together, these data suggest that Grem1 starts being expressed by
postmitotic cortical neurons destined for deep layers at E13.5
(Fig. 1C).
Global transcriptomic analysis defines transcript modules
enriched in Grem1-expressing cells
To further characterize Grem1 expressing cells in the developing
mouse brain, we undertook mRNA-seq analysis on TdTomato+ and
TdTomato− cells from the telencephalon. Pregnant Grem1creERT;
Rosa26LSLTdtomatomice were administered tamoxifen at 13.5 dpc
and embryonic brains were collected at 14.5 dpc. At this time point
almost all TdTomato+ cells expressed endogenous Grem1 RNA
(Fig. 1D,E). Dissociated brain cells were flow sorted and live
TdTomato+ and TdTomato− cells were collected for transcriptomic
analysis. TdTomato+ cells accounted for 5.1±2.1% of all live cells
(n=5; mean±s.d.) (Fig. 2A). Bulk mRNA sequencing of TdTomato+
and TdTomato− populations and analysis of 1845 differentially
expressed genes (DEG) between the two cell populations revealed
that Grem1 was significantly upregulated in TdTomato+ cells and
BMP transcriptional target genes (Id1/3/4) were significantly
downregulated [adjusted P-value (FDR)≤0.05; Fig. 2B]. We next
undertook a correlation analysis to identify modules of the 1845
DEGs that are coordinately regulated in TdTomato+ cells (Fig. S2).
Shared membership of a module can suggest genes that together
perform a particular function. The clustering tree depicts the
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Fig. 1. See next page for legend.
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topological distance between different modules, i.e. how similar or
different the expression of transcripts within the module are from
other modules, and highlighted one module that contained 288
genes with particularly tightly correlated transcripts (magenta,
Fig. S2). Network visualization of the correlation analysis showed
that the majority of transcripts within this tightly correlated module
are upregulated in TdTomato+ cells (magenta square, Fig. 2C).
We investigated the known function of genes within this module
using a hypogeometric test for gene set enrichment. Significantly
enriched pathways (adjusted P value (FDR) ≤0.001) were related to
neuronal differentiation and projection, calcium signaling (possibly
associated with synapse functions) and axons (Fig. 2D). The BMP
target gene Id1 was identified as one of the central hub genes in this
cluster and its expression was significantly associated with other
transcripts that have functions in neuronal maturation (such as
Lrrtm3, Ryr3) (Fig. 2E). Consistent with our earlier identification of
Grem1-expressing cells as committed neurons in vivo, this suggests
that neuronal functions are upregulated in the Grem1-expressing
TdTomato+ cells of the developing telencephalon.
Grem1/GREM1 is enriched in excitatory neuronal lineage
cells during brain development
To further characterize the Grem1-expressing TdTomato+ cell
population we undertook a candidate gene profiling approach using
the bulk mRNA-seq data. Gene expression patterns of neuronal
markers from a series of differentiation stages are shown in
Fig. 3A. Immature neuronal markers, such as Dcx, Ncam1,
Neurod2/6 and Tbr1, were significantly upregulated at the RNA
level in TdTomato+ cells in comparison with the TdTomato− cells at
14.5 dpc, whereas neural stem cell, radial glia and intermediate
progenitor transcripts were significantly under-represented
(FDR<0.05, quasi-likelihood F-test). When RGCs (marked by co-
expression of Sox2 and Pax6) generate neocortical neurons, the
expression of specific transcription factors can be used to identify
neurons within particular cortical layers (Franco et al., 2012; Chen
et al., 2005). Our bulk RNA-seq analysis showed that transcripts
encoding the layer V marker Fezf2 and VI markers Tbr1 and Sox5
were significantly upregulated in Grem1-expressing TdTomato+
cells, whereas the RGC markers Sox2 and Pax6 and an intermediate
progenitor marker, Tbr2 (Eomes), were significantly downregulated
(absolute value of log2 fold change≥2.0, FDR<0.05) and did not
appear to colocalize with TdTomato at 14.5 dpc using IHC
(Fig. S3).
To assist with identification of the neuronal subtype likely
generated from Grem1-expressing TdTomato+ cells, we also
performed Gene Set Enrichment Analysis (GSEA) on DEG
transcripts between TdTomato+ and TdTomato− cells. We found
a significant enrichment of a glutamate secretion gene set in the
DEGs [normalized enrichment score (NES)=2.16, P=0.0049]
(Fig. 3B), whereas GABAergic and dopaminergic gene sets were
not enriched (NES=−0.93, P=0.75; NES=−0.69, P=0.87,
respectively) (Fig. S4A). Consistent with the GSEA,
glutamatergic neuron markers, such as Slc17a7 (vGlut1), Grin1
and Grin2b were significantly upregulated in Grem1-expressing
cells at 14.5 dpc using a candidate gene approach, whereas
gabaergic and dopaminergic neuron markers, such as Slc6a1
(GABA transporter 1), Gad1, Gad2, and Th (tyrosine hydroxylase)
were significantly downregulated (P<0.05, Fig. S4B). Tbr1 plays a
central role in the development of early-born cortical excitatory
neurons and regulates the connectivity of layer VI neurons (Hevner
et al., 2001). To confirm that Grem1+ cells generate excitatory
neuronal lineages, we undertook immunohistochemical staining
with Tbr1. This revealed thatGrem1-expressing TdTomato+ cells at
14.5 dpc expressed Tbr1 at the mRNA level, but very low to no
Tbr1 at the protein level; however, Grem1-TdTomato+ cells did
become Tbr1+ neurons in cortical layer VI by 20.5 dpc (Fig. 3C,D).
To understand the relevance of our mouse focused study to the
human setting, we reanalyzed publicly available human scRNA-seq
data generated from human brain at mid-gestation (22-23 weeks
post-conception) (Fan et al., 2018). We categorized each human cell
in the dataset as either GREM1+ or GREM1− based on the presence
or absence of GREM1 RNA-seq counts for each cell. Next, we
compared the transcriptional profiles of our mouse embryonic brain
Grem1-expressing TdTomato+ cells and TdTomato− cells with the
human mid-gestational brain GREM1+ and GREM1− cells using a
multidimensional scaling plot (Fig. S4C). Samples within the same
group cluster tightly together, dimension 2 separates the samples
along species lines, whereas dimension 1 clearly shows a similar
separation of samples based on altered expression profiles
depending on the Grem1/GREM1 status in mouse and human
developing brain (Fig. S4C). Mapping the GREM1+ cells onto a
tSNE plot generated from the human scRNA-seq data revealed that
mostGREM1-expressing cells accumulated in the excitatory neuron
cluster within the human mid-gestational cortex (Fig. 3E). Re-
analysis of a mouse scRNA-seq cortical neuron dataset (Yuzwa
et al., 2017) also confirmed that expression of Grem1 most highly
correlates with the excitatory neuron cluster marked by Foxp2
(marker of layer VI) and Ctip2 (marker of layer V/VI) and not
precursor or progenitor populations (Fig. S5D). Lastly, we analyzed
the expression of other BMP-signaling components in both scRNA-
seq datasets (Fig. S5A-D). Of the pathway antagonists similar to
GREM1, sclerostin domain-containing protein 1 (SOSTDC1),
CHRD, BMP binding endothelial regulator (BMPER) and
follistatin (FST) transcripts were highly enriched in the excitatory
neuron or Cajal-Retzius cell clusters, whereas NOG expression
correlated only with the astrocyte population in the human data that
Fig. 1. Grem1-expressing cells give rise to cortical neurons in the
developing mouse brain. (A) Schematic showing tamoxifen and BrdU
administration to Grem1creERT; Rosa26LSLTdTomato (Grem1-reporter)
mice. (B) Representative images of TdTomato+ (red) cells in the
telencephalon shown with red boxes in A, at 14.5 dpc (24 h post-induction),
17.5 dpc (3 days post-induction) and 20.5 dpc (6 days post-induction) in
Grem1-reporter mice treated with tamoxifen at 13.5 dpc, and DAPI staining
(blue). (C) Schematic showing Tdtomato traces cells differentiating to layer V
and VI neurons. (D) Representative images of immunohistochemical staining
of boxed region from B to visualize TdTomato+ cells (red) and Grem1 mRNA
by ISH (green) at 14.5 dpc (I, 24 h post-induction), 17.5 dpc (II, 3 days post-
induction) and 20.5 dpc (III, 6 days post-induction) in Grem1-reporter mice
treated with tamoxifen at 13.5 dpc, and DAPI staining (blue). The boxed areas
were further magnified in adjacent panels. (E) Quantification of D showing the
percentage of TdTomato+ cells that were also Grem1 RNA+ in four high-power
fields (HPFs) of four biological replicates. One way ANOVA with Tukey’s
multiple test. (F) Representative images of immunofluorescence staining of
17.5 dpc telencephalon from Grem1-reporter (red) mice induced with
tamoxifen at 13.5 dpc: BrdU, green; DAPI, blue. (G) Quantification of F
showing the percentage of TdTomato+ cells that were also BrdU+ – two HPFs
of three biological replicates, two-tailed, unpaired t-test. (H) Representative
images of immunofluorescence staining of 14.5 neocortex from Grem1-
reporter (red) mice induced with tamoxifen at 13.5 dpc: NeuN, green; DAPI,
blue. MZ, marginal zone; CP, cortical plate; SP, subplate. (I) Representative
images of immunofluorescence staining of 20.5 dpc neocortex from Grem1-
reporter (red) mice induced with tamoxifen at 13.5 dpc: NeuN, green; DAPI,
blue; Ctip2, white. Layer V and VI recognized with Ctip2 are boxed in (i) and
(ii), respectively. (J) Quantification of H showing the percentage of TdTomato+
cells that were also NeuN+ in three HPF from three biological replicates. One
way ANOVA with Tukey’s multiple test. **P<0.01, ***P<0.001, ****P<0.0001.
Data are mean±s.d. Scale bars: 200 µm (B); 20 µm (D); 50 µm (F,H,I).
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contained a broad selection of neuronal and non-neuronal cell types
(Fig. S5A). This analysis of BMP antagonist expression was further
extended by the increased resolution of neuronal cell clusters found
in the multi-time point and neuronal-restricted mouse scRNA-seq
dataset, to be enriched in excitatory neurons and apical precursors/
RGCs (Fig. S5D). BMP2/7 that are antagonized by GREM1 were
primarily produced by alternate RGCs and IPs/excitatory neuron
populations to the Grem1-expressing excitatory neuron population
Fig. 2. Grem1-expressing cells have neuron-associated gene signatures. (A) TdTomato+ and TdTomato− cells were isolated from 14.5 dpc brains of
Grem1-CreERT; R26-TdTomato mice induced with tamoxifen at 13.5 dpc. Representative FACS plot is shown, n=5 mice sorted for bulk RNA-seq analysis.
(B) Volcano plot to show DEG between TdTomato+ and TdTomato− cells from A. Grem1 was significantly upregulated, whereas BMP target genes Id1/3/4
were significantly downregulated in TdTomato+ cells compared with TdTomato− cells. Absolute value of log2 fold change≥2.0, FDR<0.05. (C) Network
visualization of correlated DEG modules in TdTomato+ cells. Each dot represents a gene, dot perimeter color indicates module membership (see Fig. S2),
dot interior color denotes upregulation (red) or downregulation (blue) of gene transcript in TdTomato+ cells compared with TdTomato−, dot size indicates the
magnitude of gene expression correlation to neighboring genes, lines connecting dots represent topological distance. The module containing highly
correlated genes that were predominantly upregulated in TdTomato+ cells is boxed in magenta. (D) Significantly enriched gene sets in magenta boxed
module in C. FDR<0.001. (E) Genes associated with Id1, a hub gene in the magenta boxed module in C. Dot perimeter color indicates module membership
(see Fig. S2), dot interior color denotes upregulation (red) or downregulation (blue) of gene transcript in TdTomato+ cells compared with TdTomato−.
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Fig. 3. Grem1 is expressed in the glutamatergic excitatory neuron lineage cells. (A) Heatmap depicting unsupervised clustering of TdTomato+ and
TdTomato− cells isolated from 14.5 dpc Grem1-reporter (red) mice induced with tamoxifen at 13.5 dpc based on expression of representative differentiation
marker transcripts for neural stem cell (NSC), radial glia, intermediate progenitor, immature neuron and mature neuron. (B) GSEA for Glutamate Secretion
genes between TdTomato+ and TdTomato− samples from A. NES=2.16, P=0.0049. (C) Representative images of immunofluorescence staining of 14.5 and
20.5 dpc telencephalon from Grem1-reporter (red) mice induced with tamoxifen at 13.5 dpc: Tbr1, green; DAPI, blue. (D) Quantification of C showing the
percentage of TdTomato+ cells that were also Tbr1+ in three representative fields from three biological replicates. One way ANOVA with Tukey’s multiple test.
*P<0.05, ****P<0.0001. Data are mean±s.d. (E) tSNE plot of human scRNA-seq dataset. GREM1-expressing cells outlined in black. Dot size represents
Grem1 expression value as indicated. NA, not applicable. Scale bars: 100 µm.
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in the mouse developing cortex (Fig. S5D). Expression of BMP2/7
was also inversely correlated with GREM1 expression in the human
excitatory neuron cell population, suggesting paracrine BMP
pathway regulation by these opposing factors (Fig. S5C).
Expression of the BMP target genes, ID1/3/4, was inversely
correlated with GREM1-expression in excitatory neurons,
consistent with our developmental mouse brain data and
suggesting that GREM1 acts locally to antagonize BMP signaling
(Fig. 2B). BMP receptor type I and II expression correlated with
apical precursor and proliferative RGC populations (Bmpr1a/1b,
Acvr2b) and excitatory neuron clusters in the mouse scRNA-seq
dataset (Alk, Acvr1b/1/1c/2a, Bmpr2), suggesting that many of the
neurons in the developing cortex will have the ability to respond to
BMP pathway stimulation (Fig. S5A,D). This highlights the
complexity of regulation of BMP signaling during development
of the cortex.
Grem1 promotes proliferation and neural differentiation in
NSPCs ex vivo
Next we collected NSPCs from embryonic brains of Grem1flox/flox
mice at 14.5 dpc and transduced the cells ex vivo with control, Cre-
expressing or Grem1-expressing lentivirus to generate control
Grem1flox/flox, Grem1−/− and Grem1 overexpressing (Grem1O/E)
primary cultures. Endogenous Grem1 was detected in Grem1flox/flox
control cultures by western blot, with absent or elevated protein
levels in Grem1−/− and Grem1O/E cultures, respectively (Fig. 4A).
Therewere two bands, likely because of splicing variants, consistent
with previous reports (Yan et al., 2014; Koli et al., 2016). Our
method does not include selection for NSPC markers or exclusion
of committed lineage cells and so contains a heterogeneous mix of
cells that are roughly selected for proliferation potential. Because of
this, it is possible that some of this mixed population may include
immature committed neurons that express Grem1, or Grem1
expression may be aberrantly upregulated in stem/progenitor cells
by culture in vitro. ControlGrem1flox/flox cultures were responsive to
BMP pathway induction as determined by increased BRE-luciferase
reporter activity and expression of the BMP target genes Id1/2/3/4
following addition of recombinant human BMP2 (Fig. 4B,C;
Fig. S6). This induction of BRE-reporter activity and increase in
BMP target gene transcript levels was significantly enhanced in
Grem1−/− cells and attenuated in Grem1O/E cells (Fig. 4B,C;
Fig. S6). This confirmed that Grem1 acts as an antagonist of BMP2
and suppresses downstream transcriptional targets in embryonic
NSPCs. This difference was more obvious with Grem1
overexpression than genetic deletion, possibly due to limited basal
expression of Grem1 in NSPC culture.
We next employed neurosphere assays to determine the effect of
Grem1 modulation on proliferation of embryonic NSPCs. Only
mitogen-responsive cells proliferate to form clusters termed
neurospheres, where sphere size correlates with proliferative
ability (Mori et al., 2006; Reynolds and Rietze, 2005). Grem1O/E
cells form significantly more and larger neurospheres than control
Grem1flox/flox cells, whereasGrem1−/− cells form significantly fewer
(Fig. 4D,E). To understand this phenomenon from the aspect of cell
viability, we evaluated the proliferation rates of Grem1flox/flox,
Grem1−/− and Grem1O/E cultures. Overexpression of Grem1
significantly increased the rate of NSPC proliferation compared
with control Grem1flox/flox NSPCs, whereas the number of viable
Grem1−/− cells did not increase over the 72 h time course analyzed
(Fig. 4F). Our re-analysis of the mouse neuronal cortex scRNA-seq
dataset (GSE107122) showed that BMP2/7, which are antagonized
by GREM1, were primarily produced by RGCs and IPs/excitatory
neurons in the developing mouse cortex (Fig. S5D), suggesting
BMP2/7 may be produced by the NSPCs in our in vitro system.
These results suggested that Grem1 contributes to the proliferation
of NSPCs. Following on from this observation, we wanted to assess
the role of Grem1 in the differentiation of NSPCs to neurons,
astrocytes and oligodendrocytes. When cultured in recombinant
BMP2-containing differentiation media, addition of 1 ng/ml
recombinant GREM1 significantly increased the number of
NSPCs that differentiated into Tuj1+ (Tubb3+) neurons and O4+
(Foxo4+) oligodendrocyte lineage cells, and decreased the number
of GFAP+ astrocytes, in comparison with vehicle treated control
NPSCs (Fig. 4G,H). This suggests that Grem1 may regulate the
differentiation potential of NPSCs.
Grem1 is required for normal cortical development
In order to assess the functional role of Grem1 in mouse forebrain
development in vivo, we generated tissue-specific Grem1
conditional knockout mice using the empty spiracles homeobox 1
(Emx1)-cre driver. We first verified that Emx1-cre generates
efficient cre-mediated recombination in the dorsal telencephalon
at 14.5 dpc by visualizing TdTomato+ cells in reporter Emx1-cre;
Rosa26LSLTdtomato mouse brains (Fig. S7A). Next we confirmed
that Emx1-cre; Grem1flox/flox (Grem1 conditional knockout,
Grem1cKO) mice had a significant reduction in Grem1 RNA in the
developing forebrain compared with cre− littermate controls by ISH
at 14.5 dpc (Fig. 5A) and real time RT-PCR at P0 (Fig. S7B).
Grem1cKO mice were viable and fertile. To determine the
mechanistic effect of loss of Grem1 we directly analyzed BMP
pathway activity by immunohistochemical staining for the
downstream pathway effectors, phospho-SMAD1/5/8. The
number of Ctip2+ layer V/VI cells with active BMP signaling
(phospho-SMAD1/5/8+) was significantly increased in Grem1cKO
mice in comparison with Grem1flox/flox littermate controls (Fig. 5B,
C; Fig. S7C). To examine the morphological consequences of
conditional Grem1 loss in the developing mouse brain we
performed Nissl staining on tissue samples from Grem1cKO and
cre− littermate controls. At 10 weeks of age, total cortical thickness
was significantly reduced in Grem1cKO mice in comparison with
Grem1flox/flox littermate controls both in males and females, owing
to significantly thinner cortical layers V and VI as marked by Ctip2
and Foxp2 (Fig. 5D,E; Fig. S7D,E,F). Cellular density was also
lower inGrem1cKOmice in comparison withGrem1flox/flox littermate
controls (Fig. S7G,H). The number of Ki67+ proliferative cells was
unchanged both at 14.5 dpc and 20.5 dpc between Grem1cKO and
Grem1flox/flox littermate controls (Fig. S7I,J,K,L). Also the number
of Tbr2+ cells was unchanged at 14.5 dpc (Fig. S7I,J). In contrast,
the number of cleaved caspase 3+ cells was increased in Ctip2+
layers of Grem1cKO mice in comparison with Grem1flox/flox
littermate controls at 20.5 dpc, but was not different at 14.5 dpc
(Fig. 5F,H; Fig. S7M). This increase in apoptotic cells marked
by cleaved caspase 3 likely explains the significantly thinner
Ctip2+ layer we observed in Grem1cKO animals compared with
Grem1flox/flox littermate controls; however, our analyses have not
ruled out potential changes in cell proliferation or cell fate decisions
between the 14.5 and 20.5 dpc time points examined (Fig. 5G).
Conversely, the other predominant region of Emx1-cre driver
activity, the hippocampus, which has important functions in
memory for navigation pertinent to our behavioral testing,
displayed morphology and cell density that did not appear to be
different to normal on microscopic inspection (Fig. S8A).
Our earlier transcriptional network analysis from bulk RNA-seq
data identified an Id1-associated gene cluster that was differentially
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regulated in theGrem1-expressing TdTomato+ cells from the cortex
at 14.5 dpc (Fig. 2E). From this cluster, Lrrtm3 and Ryr3 were
selected for further analysis because of their known functions in
synapse development (Balschun et al., 1999; Um et al., 2016;
Roppongi et al., 2017; Futagi and Kitano, 2015; Linhoff et al.,
2009). The expression of these two transcripts was significantly
downregulated in the cortex of Grem1cKO mice compared with
littermate controls at P10 (Fig. S8B). This provides further evidence
of the relationship between Grem1 expression and these genes. To
examine the effect of Grem1 deletion on differentiation, transcript
Fig. 4. Grem1 promotes proliferation and neuronal differentiation in neural stem/progenitor cells ex vivo. (A) Detection of Grem1 protein levels in
control Grem1flox/flox, Grem1−/− and Grem1O/E NSPC by western blot. (B) BRE-reporter activity relative to internal control reporter. Data obtained from four
independent experiments each performed in triplicate. One way ANOVA with Tukey’s multiple test. (C) BMP target gene Id1 mRNA expression normalized to
Gapdh in Grem1flox/flox, Grem1−/− and Grem1O/E NSPC treated with vehicle or rBMP2 for 24 h. One way ANOVA with Tukey’s multiple test. Results from five
independent experiments performed in triplicate. (D) Representative images of Grem1flox/flox, Grem1−/− and Grem1O/E neurosphere cultures.
(E) Quantification of neurosphere number and size from D in four representative fields from four independent experiments. One way ANOVA with Tukey’s
multiple test. (F) Cell proliferation normalized to 0 h time point for each culture. Results from three independent experiments each performed in triplicate and
analyzed using linear regression. (G) Representative images of immunofluorescence staining to identify Tuj1+ neurons, GFAP+ astrocytes and O4+
oligodendrocytes in differentiated cultures from wild-type NSPCs treated with vehicle or rGrem1. (H) Quantification of G, showing the percentage of marker+
cells in three representative fields from three independent experiments. Two-tailed, unpaired t-test. Data are mean±s.d. *P<0.05, **P<0.01, ***P<0.001,
****P<0.0001. Scale bars: 100 µm.
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Fig. 5. See next page for legend.
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levels of Slc17a7 for excitatory neurons, Gfap for astrocytes
and myelin-associated glycoprotein (Mag) for oligodendrocytes
were also assessed by qPCR. Although Slc17a7 was significantly
decreased in Grem1cKO samples, there was no significant difference
in Gfap or Mag (Fig. S8B).
Motor coordination and fear responses were impaired in
Grem1cKO mice
To assess the functional consequences of embryonic Grem1 deletion
in the mouse forebrain, we undertook behavioral testing with
Grem1cKO mice in comparison with Grem1flox/flox littermate controls.
We compared motor balance using the Rotarod test. Latency to fall
was significantly shorter in Grem1cKO mice both for males and
females, suggesting an impaired motor balance following loss of
Grem1 (Fig. 5I). During the open field test used to assess exploratory
behaviors, both male and female Grem1cKO mice spent significantly
more time in the central area away from the walls than littermate
controls (Fig. 5I). The total distance moved and velocity of movement
were similar betweenGrem1cKO and littermate controls (Fig. S8C,D).
Behavioral testing using an elevated plus maze also indicated that
female Grem1cKO mice spent significantly more time in the open
maze arms and entered into the open arms more frequently than
littermate controls (Fig. 5I). Both of the exploratory behavior tests
indicated that conditional loss of Grem1 leads to reduced anxiety-
like behavior. Lastly, we used the Y maze test to assess the short-
term memory of Grem1cKO and littermate controls. We observed no
difference in the number of entries made to the novel arm of the Y
maze between groups (Fig. S8E,F), suggesting that Grem1
expression is not required for short-term memory function.
DISCUSSION
The spatiotemporal regulation of BMP signaling in brain
development is poorly understood. Here, we focus on the
expression and function of the BMP antagonist Grem1 during
brain development, using transgenic lineage tracing, gene
expression, in vitro culture and conditional knockout approaches.
In the developing mouse brain Grem1 is first expressed at
13.5 dpc in committed neurons that will differentiate into layer V
and VI neurons by 20.5 dpc (Fig. 1I; Fig. S1A,C). Transcriptomic
profiling using our mRNA-seq data from embryonic Grem1-
reporter mouse brains and publicly available mouse and human
developmental brain scRNA-seq data suggests that Grem1/GREM1
expression is primarily associated with markers of glutamatergic
excitatory neuronal lineages, rather than GABAergic or
dopaminergic neurons or other cell types of the developing brain
(Fig. 3B,E; Fig. S4A,B). Consistent with this, Grem1 was not
expressed in the ganglionic eminences, from which GABAergic
interneurons originate; nor were GABAergic transcripts upregulated
or enriched by GSEA in Grem1-expressing TdTomato+ cells in the
dorsal telencephalon using bulk RNA-seq analysis (Fig. S4A,B).
Likewise Grem1-lineage-traced cortical neurons expressed the
excitatory marker Tbr1 (Fig. 3C). Grem1-expression labels and
generates important excitatory neuronal lineages, i.e. pyramidal
neurons, which play high-level cognitive functions in the neocortex.
Grem1 expression is required for the correct development of early-
born excitatory neurons of the neocortex (Figs 1I and 5D-H).
Although we have not directly analyzed the proportion of excitatory
and inhibitory neurons in Grem1cKO animals here, misregulation of
BMP signaling might affect the balance between excitatory and
inhibitory neuronal activities, which has been implicated in
neurodevelopmental disorders (Dani et al., 2005).
Our analysis of scRNA-seq data from human midgestational
cortex (22-23 weeks post-conception) and from mouse embryonic
cortex suggests that there is coordinated regulation of BMP
signaling during development, but that there may be also be
functional redundancies (Fig. S5A,D). Nog is the most extensively
studied of the BMP antagonists in the CNS, in which it is a
recognized neural inducer during gastrulation (Lamb et al., 1993).
Addition of recombinant Nog to neural stem cells promotes
neuronal and suppresses astrocytic differentiation in vitro
(Mikawa and Sato, 2011). In our study, we confirmed that Grem1
acts as a BMP antagonist in embryonic NSPC cultures, suppressing
downstream BMP transcriptional targets (Fig. 4B,C; Figs S5C, S6).
Although Grem1 is expressed by immature but committed neurons,
rather than Sox2+ or Pax6+ neural stem or precursor populations in
vivo (Fig. S3), this in vitro study was useful to simulate the role of
secreted Grem1. Similar to Nog, we determined that Grem1
promotes proliferation and neural differentiation, at the expense of
astrocytic lineages in vitro (Fig. 4G,H). This is consistent with a
previous report that found Grem1 promotes proliferation and
suppresses astrocyte differentiation of cancer stem cells in
glioblastoma (Yan et al., 2014). Grem1cKO mice showed
decreased Slc17a7 mRNA expression, but no significant change
in glial cell differentiation, possibly due to the redundant BMP
regulatory effects by other antagonists in vivo.
Our histological analyses identified that the cortex (particularly
neocortical layers V and VI) of Grem1cKO animals is significantly
thinner, with less cells, in comparisonwith littermate controls, with no
obvious morphological changes in the hippocampus. In contrast to our
NSPC in vitro data (Fig. 4D-F), we did not observe a significant
decrease in the number of Ki67+ proliferative cells or Tbr2+
intermediate progenitors in Grem1cKO animals at 14.5 dpc or
20.5 dpc (Fig. S7I-L). However, it is possible that progenitors may
have altered proliferation or differentiation in Grem1cKO animals
between the time points analyzed. Still, the number of cleaved caspase
Fig. 5. Cortical development, motor balance and fear is impaired in
Grem1 conditional knockout mice: Grem1 is required for normal cortical
development. (A) Representative Grem1 expression in the dorsal
telencephalon of Grem1cKO mice and Grem1flox/flox littermate controls by ISH
at 20.5 dpc. n=3. (B) Representative images of immunofluorescence staining
of cortex of Grem1cKO mice and littermate controls at 20.5 dpc with layer V
and VI showing marker Ctip2 (green), phosphorylated SMAD1/5/8 (red) and
DAPI (blue) (see also Fig. S7C). (C) Quantification of phosphorylated
SMAD1/5/8+ cells in Ctip2+ cells in (B). n=4, two-tailed, unpaired t-test.
(D) Representative histological images of cortical layers of Grem1cKO mice
and Grem1flox/flox littermate controls using Nissl staining at 10 weeks of age.
(E) Quantification of cortical layer thickness from D compared in eight pairs of
male Grem1cKO mice and littermate controls at 10 weeks of age. Male, n=7
control and n=7 Grem1cKO, two-tailed, unpaired t-test. (F) Representative
images of immunofluorescence staining of cortex of Grem1cKO mice and
littermate controls at 20.5 dpc with layer V and VI showing marker Ctip2
(green), cleaved caspase 3 (red) and DAPI (blue). n=4. High magnification of
boxed areas is shown in right panels. (G) Quantification of Ctip2+ layer V/VI
and intermediate zone thickness from F compared in four pairs of Grem1cKO
mice and littermate controls at 20.5 dpc, two-tailed, unpaired t-test.
(H) Quantification of cleaved caspase 3+ cells in Ctip2+ cells in G. n=4,
two-tailed, unpaired t-test. (I) Behavioral testing was performed to compare
Grem1cKO and Grem1flox/flox mice using age and sex matched littermates at
7-10 weeks of age. (i) Rotarod test latency to fall. Male, n=14 control and
n=11 Grem1cKO; Female, n=12 control and n=13 Grem1cKO, two-tailed,
unpaired t-test. (ii) Open field test, cumulative duration spent in the center
area. Male, n=13 control and n=14 Grem1cKO; Female, n=13 control and n=13
Grem1cKO, two-tailed, unpaired t-test. (iii,iv) Elevated plus maze test.
(iii) Cumulative duration spent in open arms. (iv) The number of entries to
open arms. Male, n=12 control and n=11 Grem1cKO; Female, n=14 control
and n=14 Grem1cKO, two-tailed, unpaired t-test. Data are mean±s.e.m.
*P<0.05, ***P<0.001, ****P<0.0001. Scale bars: 100 µm.
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3+ apoptotic cells was increased in cortical layers V/VI in the absence
of Grem1 in Grem1cKO animals at 20.5 dpc, whereas Ctip2 and
cleaved caspase 3were not changed at 14.5 dpc (Fig. 5F,H; Fig. S7M).
This suggests that apoptosis was increased in Grem1cKO after
14.5 dpc, which could contribute to the thinner deep cortical layers
in these animals after birth in comparison with littermate controls.
Although secreted Grem1 can influence the upper as well as
deep-layer neurons, we did not observe any noticeable changes to
downstream BMP pathway activity in the upper layer neurons of
Grem1cKOmice in comparison withGrem1flox/flox littermate controls
as indicated by phospho-SMAD1/5/8 staining (Fig. 5B,C;
Fig. S7C). We did however observe an increase in phospho-
SMAD1/5/8 staining in Ctip2+ deep-layer neurons in Grem1cKO
mice in comparison with Grem1flox/flox littermate controls. BMP
transcriptional targets were significantly downregulated in Grem1-
expressing TdTomato+ cells in vivo (Fig. 2B) and Grem1+ excitatory
neurons in the human embryonic cortex (Fig. S5C). An upper layer
neuron marker, Cux1, and expression of BMP receptors Bmpr1a/1b
and Avcr2b correlated with apical precursor and proliferative RGC
populations, whereas deep-layer neuron markers Foxp2 and Ctip2,
and BMP receptors Alk, Acvr1b/1/1c/2a and Bmpr2 expression
correlated with excitatory neuron or newborn neuron clusters in the
mouse scRNA-seq cortical neuron dataset (Yuzwa et al., 2017)
(Fig. S5D). This suggests that BMP receptors are expressed both in
upper and deeper layer cortical neurons, although with specific cell-
type expression patterns for each receptor. Conversely, BMPs are
produced by endothelial cells, astrocytes and excitatory neurons in
human (Fig.S5B). In the mouse cortex, BMPs are produced by
RGCs and IPs/excitatory neuron populations, according to single
cell analysis of neuronal lineage cells (Fig. S5D), and also from the
meninges (Choe et al., 2012) (Fig. S5E). Although Grem1 is
secreted, it usually acts on nearby or adjacent cells (Worthley et al.,
2015). This could explain why downstream SMAD signaling is
most affected in deep-layer neurons in which Grem1 is
predominantly expressed. Together these results suggest that
Grem1-expressing cells are fated to become neurons via
antagonism of potential paracrine BMP signals (Fig. S5E) (Furuta
et al., 1997; Imura et al., 2008; Choe and Pleasure, 2018).
Layer V neurons target the spinal cord, cerebellum, striatum and
the thalamus (Shipp, 2007) and play roles in movement preparation,
movement guidance and the execution of well-timed movements
(Baker et al., 2018; Li et al., 2015). The observed decrease in layer V
neurons would lead to impaired preparation for and coordination of
movement in Grem1cKO animals and explain the motor balance
defect in these animals in comparison with litter mate controls.
Emerging evidence suggests that layer VI neurons play a central role
in modulating thalamic and cortical neurons during sensory
processing (Wang et al., 2016). Our behavioral testing confirmed
that loss of Grem1 expression significantly impaired fear sensitivity
in Grem1cKO animals, compared with littermate controls, consistent
with a deficiency in layer VI neurons with roles in sensory
connections. BMP signaling is known to promote synaptogenesis
(Xiao et al., 2013; Shen et al., 2004) and altered synaptogenesis can
affect both fear sensitivity andmotor abilities (Ha et al., 2016;Wood
and Shepherd, 2010). Network analysis of DEG between Grem1-
expressing TdTomato+ and TdTomato− cells from the developing
mouse dorsal telencephalon identified a gene cluster of inter-related
transcripts in which the BMP target gene, Id1, acts as a hub. Genes
in the cluster play roles in neuron morphogenesis, synapse and axon
maturation (Fig. 2D,E). For example, Lrrtm3/4 encode synapse
organizing proteins crucial for the development and function of
excitatory synapses (Um et al., 2016; Roppongi et al., 2017; Linhoff
et al., 2009). Likewise, Ryr3 encodes a member of a family of
receptors that shape synaptic transmissions(Balschun et al., 1999)
by amplifying spike-driven calcium signals in presynaptic
terminals, and consequently enhancing the efficacy of transmitter
release (Futagi and Kitano, 2015). InGrem1cKO animals, the mRNA
expression of Lrrtm3 and Ryr3 was significantly decreased in
comparison with littermate controls (Fig. S8B). This is possibly
because of a loss of excitatory deep-layer neurons in the gross cortex
tissue samples from Grem1cKO animals compared with Grem1flox/
flox littermate controls, rather than indicating a direct role for Grem1
in the regulation of synaptogenesis. However the potential role for
Grem1 and other BMP modulators in neuron morphogenesis,
synapse and axon maturation in the developing cortex warrants
further interrogation.
In summary, this is the first study to reveal the important function
of Grem1 in cortical development. Grem1 is expressed and essential
for survival of committed deep-layer cortical neurons. In the future,
Grem1may hold value beyond understanding the cellular biology of
brain development and function as we develop new approaches to
help tackle complex neurodevelopmental and neurological diseases.
MATERIALS AND METHODS
Mice
Grem1-CreERT transgenic mice (Worthley et al., 2015) were crossed with
R26-LSLTdTomato mice [B6.Cg-Gt(ROSA)26Sortm14(CAG−tdTomato)Hze/J;
JAX 007914] to generate a tamoxifen-induced Grem1 reporter line.
Pregnant dams were administered 6 mg of tamoxifen by oral gavage to
induce embryonic Grem1-tracing, with some dams bearing 13.5 dpc
embryos also intraperitoneally injected with BrdU (Roche, 40 mg/kg) to
track cell division. Grem1flox/flox mice (Gazzerro et al., 2007) were crossed
with Emx1-cremice (B6.129S2-Emx1tm1(cre)Krj/J; JAX 005628) to generate
Emx1-cre-mediated Grem1 conditional knockout mice (Emx1-cKO). The
line was maintained by crossing Emx1cre/+; Grem1flox/flox mice with
Grem1flox/flox mice.
All mice were on the C57BL6/J background and experimentation was
conducted following approval by South Australian Health and Medical
Research Institute (SAHMRI) Animal Ethics Committee (approval number
SAM284) in accordance with the Australian Code for the Care and Use of
Animals for Scientific Purposes (8th edition).
Preparation of single cell suspensions and flow cytometry
Pregnant Grem1creERT; Rosa26LSLTdTomato mice were administered
tamoxifen at 13.5 dpc. At 14.5 dpc, dorsal telencephalons of the embryos
were dissected in cold phosphate-buffered saline (PBS) and the meningeal
membranes were removed. Neurocult Enzymatic Dissociation kit (Stemcell
Technologies) was used for cell dissociation according to the manufacturer’s
protocol. Dissociated cells were resuspended in fluorescence-activated cell
sorting (FACS) buffer containing DAPI (0.5 µg/ml). Sorting and analyses
were carried out on a FACS Fusion flow cytometer (Becton-Dickinson).
Dead cells were excluded by gating on forward and side scatter and by
eliminating DAPI+ events. The cells harvested from cre− littermate control
mice were used to set background fluorescence levels. Viable cells were
sorted into FACS buffer, collected via centrifugation (300 g) and
resuspended in Trizol (Invitrogen) for RNA extraction.
RNA extraction and mRNA-seq
RNA was extracted from sorted cells in Trizol according to the
manufacturer’s protocol with the exception of addition of glycogen
(20 µg/µl) and isopropanol precipitation overnight at −80°C to maximize
yield. RNA quality and quantity were analyzed using a NanoDrop and
TapeStation (Thermo Scientific). Total RNA was converted to strand-
specific Illumina-compatible sequencing libraries using the Nugen
Universal Plus mRNA-Seq library kit from Tecan (Mannedorf ) as per the
manufacturer’s instructions (MO1442 v2). Briefly, 500 ng of total RNAwas
polyA selected and the mRNA fragmented before reverse transcription and
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second strand cDNA synthesis using dUTP. The resultant cDNA was end
repaired before the ligation of Illumina-compatible barcoded sequencing
adapters. The cDNA libraries were strand selected and PCR amplified for 12
cycles before assessment by Agilent Tapestation for quality and Qubit
fluorescence assay for quantity. Sequencing pools were generated bymixing
equimolar amounts of compatible sample libraries based on the Qubit
measurements. Sequencing of the library pool was performed with an
Illumina Nextseq 500 using single read 75 bp (v2.0) sequencing chemistry.
Bioinformatic analysis
RNA-seq data processing
Fastq files from the sequencing run were subjected to quality controls with
FastQC version 0.11.3. Raw reads with low quality were removed using
Trim Galore alignment (Phred score less than 28 and/or reads contains
adaptor sequences). After trimming, all bases with low quality scores and
adaptor sequences were removed. The trimmed reads were mapped to
Ensembl mouse genome (GRCm38) with STAR 2.4.2a. No more than one
base mismatch was allowed. Only uniquely mapped reads were retained.
Option -quantMode was enabled to generate gene level quantification. The
counts files were then merged into an expression table for downstream
differential expression analysis.
Differential expression analysis
DEG between the TdTomato+ (Grem1+) and TdTomato− (Grem1−)
populations were analyzed with edgeR packages in R version 3.6.0
(Robinson et al., 2010). Reads were inspected through a multidimensional
scaling plot and outliers were removed. Weighted trimmed mean of M
values (TMM) normalized counts were log2-transformed and counts per
million (CPM) obtained. Paired comparisons between the TdTomato+
(Grem1+) and TdTomato− (Grem1−) populations were performed. DEG
reported as significant were selected by requiring both adjusted P-value
(FDR) ≤0.05 and absolute value of log2 fold change ≥2.0.
Supervised Weighted Gene Correlation Network Analysis (WGCNA)
Only DEGs were used for subsequent network analysis. The gene network
was constructed using the R package supervised weighted gene correlation
network analysis (WGCNA) following the procedure previously described
(Langfelder and Horvath, 2008). After the low expression genes (FPKM<1)
had been filtered out from all gene expression libraries, Pearson’s
correlation-based adjacency was calculated on the basis of pairwise
correlations of gene expression within TdTomato+ (Grem1+) samples.
Topological overlap of the correlations was used to weight the edges of the
correlation network. The higher the weight, the stronger the interaction
between two genes. Connectivity for a single genewas calculated as the sum
of weights relative to the rest of the genes, and the top 5% of genes with the
highest connectivity in the network defined as hub genes. For visualization,
a heat map was generated using the TOMplot() function in WGCNA R
package (version 1.68), with dissimilarity topological overlap (1–
topological overlap), employed for hierarchical clustering. To generate the
network plot, theweights of the network were cut off at 0.1. Hypergeometric
enrichment tests for each module-defined gene list were performed with the
enricher() function, as part of clusterProfiler R package version 3.13.0 (Yu
et al., 2012). Bonferroni adjustment for P-value was used, only gene sets
with an adjusted P-value <0.05 were considered for interpretation of the
biological function modules.
Gene set enrichment analysis
To use the Molecular signatures database (MSigDB), we accessed all gene
sets (.gmt file, version 6.2) from the Broad Institute, MA, USA, and chose a
subset for further analyses including BioCarta, Hallmark, Gene Ontology
(GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), Pathway
Interaction Database and the Reactome Pathway Database. To enable cross
species comparisons, mouse gene ensembl IDs were converted to human
orthologous gene symbols using biomaRt R package, version 2.41.7
(Durinck et al., 2009). Humanized gene lists for the whole transcriptome
were ranked based on logfc values by comparing TdTomato+ and
TdTomato− cells. The R package clusterProfiler version 3.13.0 (Yu et al.,
2012) was used to scan through all the gene sets mentioned above, using
Benjamini–Hochberg adjusted P-values.
Analysis of publicly available scRNA-seq dataset
scRNA-seq raw expression data was accessed for human mid-gestational
brain (22 and 23 weeks post-conception) cortex samples from GSE103723
(Fan et al., 2018). The cells from two individual samples were grouped
together, with the sum of reads calculated for each gene to represent the data
structure of bulky transcriptomics. The limma package (Ritchie et al., 2015)
was used to remove batch effects with removeBatchEffect() and to generate
multidimensional scaling plots. To understand the expression pattern of
human GREM1 and its possible contribution to neural differentiation,
normalized counts and tSNE coordinates were employed for visualization
using plots generated with ggplot2 package in R environment (Wickham,
2009). To investigate cell types expressing BMP antagonists, Pearson’s chi-
squared test of independence was performed in the R environment with
chisq.test() function. Testing variables were gene expression categorized
into high and low by median expression, and using cell type identifiers from
the original scRNA-seq study (Fan et al., 2018). Scaled standardized
residuals for each gene were used to plot the heatmap using the
ComplexHeatmap package (Gu et al., 2016).
To examine the neural cell populations of the cortex expressing Grem1
throughout developmental stages with single cell resolution in mice, we re-
analyzed an scRNA-seq dataset with R version 4.0.3 (Yuzwa et al., 2017).
Data were obtained from the Gene Expression Omnibus (GSE107122). We
combined E11.5, E13.5, E15.5 and E17.5 together and analyzed with Seurat
version 3.0 (Stuart et al., 2019). Data were firstly clustered by setting the
dimension 1 to 16 and the resolution at 2 to obtain larger cell numbers within
each cluster. Markers for each cluster were calculated through the
FindAllMarkers() function, using receiver operating characteristic (ROC)
analysis with minimum fraction set at 0.25 and log fold change set at 0.25.
The top markers for each clusters were compared with the markers list
from the original publication and clusters condensed to eight clusters
according to the authors’ original markers: apical precursor – Sox2, Pax6,
Hes1, Hes5, Pcna, Ung; proliferative RGC – Sox2, Pax6, Hes1, Hes5,
Slc1a3, Ki67; nonproliferative RGC – Sox2, Pax6, Hes1, Hes5, Slc1a3;
excitatory neuron – Tbr1, Tuj1, Satb2, Bhlhe22; newborn neuron – Tbr2,
Tuj1, Tbr1, Foxp2, Rein; intermediate progenitor (IP)/excitatory neuron –
Tbr2, Sstr2, Mfap4, Unc5d, Sema3c, Tuj1, Tbr1; apical IP – Tbr2,
Gadd45g, Ngn1 (Neurog1), Ngn2 (Neurog2), Btg2, Sstr2, Mfap4; basal IP –
Tbr2, Neurod1, Pam, Slc17a6, Sstr2, Mfap4 (Yuzwa et al., 2017). To
examine the association between expression of genes of interest (BMP
pathway and additional marker genes) and cell clusters, we categorized the
expression of genes of interest into high and low expression groups at
median expression. We then performed chi-squared tests using base
function chisq.test() to look for correlations between gene expression and
cell cluster. The standardized residuals for each gene were then visualized
using a heatmap with ComplexHeatmap package (Gu et al., 2016).
In situ hybridization
ISH analyses were performed on frozen mouse tissue samples using
RNAscope technology (RNAscope 2.5 HD Detection Kit, Advanced Cell
Diagnostics) following the manufacturer’s instructions. Briefly, tissue
sections were fixed by 4% paraformaldehyde (PFA) for 15 min, followed by
incubation with an H2O2 solution (Pretreat 1 buffer) for 10 min at room
temperature. Slides were boiled in a target retrieval solution (Pretreat 2
buffer) for 5 min, followed by incubation with a protease solution (Pretreat 3
buffer) for 30 min at 40°C. Slides were incubated with a mouse Grem1
probe and a negative control probe (NM_011824.4, region 398-1359,
catalogue number 314741 and 310043) for 2 h at 40°C, followed by
successive incubations with signal amplification reagents. ISH staining was
visualized with alkaline phosphatase substrate and Fast Red. Combined
ISH/IHC was undertaken by first performing ISH, followed by IHC. For
IHC following ISH, the sections were blocked with blocking buffer (X0909,
Dako) and then incubated with a primary antibody (rabbit polyclonal anti-
RFP, Rockland, 600-401-379, 1:1000) overnight at 4°C. The sections were
washed in 1× phosphate-buffered saline 0.1% v/v Tween (PBST) three times
and then incubated with HRP-conjugated secondary antibody (Vector
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Laboratories, PI-1000-1, 1:200) for 60 min at room temperature. IHC
staining was visualized with Universal Elite ABC Kit (PK6101, Vector
Laboratories) and DAB (K3468, Dako) and slides were counterstained with
hematoxylin, dehydrated in ethanol, cleared in xylene and coverslipped.
Cells expressing more than one ISH signal were regarded as positive for
Grem1 RNA.
Real time RT-PCR
RNeasy mini kits (Qiagen) were used to isolate RNA from snap-frozen
mouse brain tissues. RNA was reverse-transcribed into cDNA with cDNA
master (Sigma-Aldrich). PCR amplification was performed with Kappa
Sybr qPCR mix or Kappa Probe qPCR mix using QuantStudio7 (Applied
Biosystems). The mouse Gapdh gene was used as an endogenous control.
The following primers were used: TaqMan probes and primers – gremlin 1
(IDT, Mm.PT.58.11631114), Id1 (IDT,Mm.PT.58.6622645.g), Id2 (IDT,
Mm.PT.58.13116812.g), Id3 (IDT, Mm.PT.58.29482466.g), Id4 (IDT,
Mm.PT.58.6851535); Sybr primers – Gapdh-forward AAGGTCATCCCA-
GAGCTGAA, Gapdh-reverse CTGCTTCACCACCTTCTTGA, Ryr3-
forward TGCTGTCGCTTCCTTTGCTA, Ryr3-reverse CATCGATGG-
GGACGCTAGAC, Lrrtm3-forward TAGCAAATCAGGCTCCAGGG,
Lrrtm3-reverse GAGTTCATGATGGACCCCACA, MAG-forward CCAG-
TACACCTTCTCGGAGC, MAG-reverse TCCGGCACCATACAACT-
GAC, Gfap-forward ACCGCATCACCATTCCTGTA, Gfap-reverse TG-
TGACTTTTTGGCCTTCCC, Slc17a7-forward CTTTTTGCGCAGTCGT-
CACA, Slc17a7-reverse GAGTATCCGACCACCAGCAG.
Immunohistochemistry
To collect 14.5 dpc, 17.5 dpc and 20.5 dpc embryonic brains, euthanized
pregnant dams immediately underwent cardiac perfusion with 4% PFA.
Whole embryos at 14.5 dpc or dissected embryonic brains for 17.5 and
20.5 dpc were fixed in 4% PFA at 4°C overnight. Embryos and brains were
then cryoprotected in 30% sucrose and frozen in OCT embedding medium.
Then, 16 µm sections were cut using a Leica CM1900 cryostat. To make
paraffin sections, samples were post fixed in 10% neutral buffered formalin
overnight and processed. Then, 5 µm sections were cut using a Leica
HM325 microtome. Sections were blocked with Protein Block Serum-Free
(Dako) for 1 h at room temperature, incubated overnight with first antibody
at 4°C, secondary antibody for 1 h at room temperature, and coverslipped
with Vectashield Antifade Mounting Medium (Vector Laboratories). The
following antibodies were used: anti-TBR1(Abcam, ab183032, 1:400), anti-
NeuN (Abcam, ab104225, 1:500), anti-β tubulin III (Sigma-Aldrich,
T5076, 1:400), anti-O4 (R&D Systems, MAB1326, 1:500), anti-GFAP
(Dako, Z0334, 1:250), anti-FOXP2 (Abcam, ab16046, 1:10,000), anti-
Ctip2 (Abcam, ab18465, 1:800), anti-CDP (Santa Cruz Biotechnology, sc-
13024, 1:400), anti-BrdU (Abcam, ab6326, 1:600), anti-RFP (Rockland,
600-401-379, 1:1000), anti-Sox2 (Millipore, AB5603, 1:400), anti-Pax6
(Millipore, AB2237, 1:100), anti-TBR2 (Abcam, ab183991, 1:400), anti-
Ki67 (Cell Signaling Technology, #12202, 1:200), anti-cleaved caspase 3
(Cell Signaling Technology, #9661, 1:400), anti-phospho SMAD1/5/8
(Millipore, AB3848-I, 1:200). Images were acquired on a Leica SP5 spectral
scanning confocal microscope.
Neural stem cell and progenitor cell culture
Before seeding cells, tissue culture dishes were coated with poly-D-lysine
(PDL) (100 µg/ml) and laminin (10 µg/ml). Embryonic NSPCs were
isolated from pregnant mice at 14.5 dpc. Dorsal telencephalons were
dissected from each embryo in PBS, meningeal membranes removed and
the tissue triturated to a single cell suspension. Cells were cultured
in NeuroCult Proliferation Medium containing 20 ng/ml epidermal growth
factor (EGF) (Stemcell Technologies). For differentiation assays, cells
were seeded onto four-well chamber slides (Thermo Fisher Scientific,
#NUN177399) in Neurocult Differentiation medium (Stemcell
Technologies). To induce recombination or overexpression of Grem1,
cells collected from Grem1flox/flox embryos were infected with plenti-EF1-
Cre-2a-sfGFP-2a-puro, plenti-EF1-Grem1-2a-sfGFP-2a-puro or plenti-
EF1-2a-sfGFP-2a-puro lentivirus, and transduced cells were selected using
puromycin for 5 days and used for experiments before passage 5. Lentivirus
plasmids psPAX2 and MD2.G were transfected to 293T cells to generate
lentivirus, and viral supernatant was concentrated using Amicon-Ultra 100k
spin columns. To assess neurosphere forming ability, cells were seeded in 6-
well uncoated plates (1.6×105 cells per well) and cultured for 5 days. The
number of neurospheres sized 50-100 µm and >100 µm was counted. For
cell viability assays, NSPCs were seeded in 96-well coated plates (1×104
cells per well) and RealTime-Glo™ MT Cell Viability Assay (Promega)
was used with the continuous-read protocol at 0, 24, 52 and 72 h.
Recombinant human BMP2 (Prospec) was added to the differentiation
medium.
Luciferase assay
BMP pathway activity was measured using the BMP response element
luciferase reporter pGL3 BRE luciferase (Addgene plasmid #45126),
internal control pRL/TK-luciferase reporter and the dual luciferase reporter
assay kit (Promega). NSPCs were seeded in coated 24-well plates (1.6×105
cells per well) and transfected with the reporter plasmids using
xTremeGENE HP DNA transfection reagent (Roche). Cells were
collected 48 h after transfection using Passive lysis buffer (Promega). The
pGL3 empty vector was used as a control for BMP-independent changes in
reporter activity.
Western blot
Cell lysates were solubilized with M-PER Mammalian Protein Extraction
Reagent (Thermo Scientific) containing complete protease and phosphatase
inhibitors. Lysates were separated by SDS-PAGE and transferred to
PVDF membranes (Millipore). After blocking with 5% nonfat skim milk
in PBST for 30 min at room temperature, the membranes were incubated
overnight at 4°C with anti-gremlin 1 antibody (R&D Systems, AF956,
1:1000) or anti-β-actin (Santa Cruz Biotechnology, sc-47778, 1:1000) in
0.5% nonfat skim milk in PBST. Membranes were washed with PBST
and incubated with alkaline phosphatase-conjugated secondary antibodies
(anti-rabbit IgG and anti-mouse IgG, GE Healthcare Life Sciences, NA934,
NA931, 1:10,000) for 1 h at room temperature. Finally, the blot was
visualized with Immobilon HRP substrate (Millipore) using a Chemi Doc
XRS1 (Bio-Rad).
Behavioral tests
Mice were submitted to Rotarod, open field, elevated plus maze and Ymaze
tests at the age of 7-10 weeks. Mice in their home cages were acclimatized to
the behavior suite for at least 30 min before testing. The data was acquired
blindly to the genotype.
Rotarod: animals were placed on the rotarod (Panlab/Harvard Apparatus)
that linearly increased rotation speed from 4 to 40 rpm during a 120 s period.
An accelerating protocol was employed to eliminate the need for habituation
to the rotarod. This procedure was repeated for a total of three trials per
mouse, separated by 15 min inter-trial intervals and the mean latency to fall
from the rotarod in seconds was compared between wild-type littermate
controls and Grem1cKO mice to assess motor coordination.
Open field test: the open field test was conducted in four identical square
arenas (50×50×50 cm) surrounded by walls. Mice were individually placed
in a corner of a clean arena and allowed to explore for 10 min. For the
purpose of data collection, the arena was conceptually partitioned into two
zones: a virtual center zone of 23×23 cm and a peripheral zone occupying
the remaining area. A lower percentage of time spent in the center zone was
used to indicate a higher level of anxiety.
Elevated plus maze test: the elevated plus maze consisted of a central
square (8×8 cm) and four arms (29 cm long×8 cmwide, two open arms with
no railing and two closed arms enclosed by a transverse wall 20 cm in
height). A mouse was placed in the center of the central square facing the
open arm and allowed to explore the maze apparatus for 10 min. The time
spent in any of the open arms was recorded and used as a measure of anxiety.
Y-maze test: the apparatus consisted of three arms with an angle of 120°
between each of the two arms. Each arm was 40 cm long×8 cmwide×15 cm
high. Visual cues were placed on the walls of the mazes. The Y-maze test
consisted of two trials separated by an inter-trial interval (ITI) to assess
spatial recognition memory. The first trial (training) had a 5 min duration
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and allowed the mouse to explore only two arms of the maze, with the third
arm (novel arm) being blocked. After 30 min ITI, the second trial was
conducted, during which all three arms were accessible for 5 min. Trials
were recorded using a ceiling-mounted camera and analyzed by a video
analyzer (Ethovision XT, Noldus) to determine the period that each mouse
spent in each arm of the maze.
Statistics
All statistical analyses were performed using Graphpad prism 8, with
methods and values summarized in each figure legend.
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